Paul Scherrer Institute PSI

(IN BRIEF) Researchers at PSI have made a surprising discovery that could expand the medical applications of botulinum toxin A1, commonly known as Botox. They have developed antibody-like proteins called DARPins that unexpectedly accelerate the toxin’s impact on nerve signal … Read the full press release →

(IN BRIEF) The Paul Scherrer Institute (PSI) has administered proton radiotherapy to a 67-year-old patient with oesophageal cancer, marking the first time this treatment has been used in Switzerland for such a case. The treatment is part of a collaborative … Read the full press release →

(IN BRIEF) Researchers from the Paul Scherrer Institute (PSI) and ETH Zurich, along with the Baden Cantonal Hospital and University Hospital Zurich, have developed a refined method of mammography, an x-ray imaging technique used for detecting breast cancer. The new … Read the full press release →

(IN BRIEF) Researchers at the Paul Scherrer Institute (PSI) and the University of Barcelona have provided experimental proof for the behavior of microgels, soft particles made of polymers, in colloids. The phenomenon, known as the shrinking of microgels, occurs when … Read the full press release →

(IN BRIEF) Researchers at the Paul Scherrer Institute (PSI) have developed a new drug that shows promise in increasing the survival chances of patients with metastatic prostate cancer. The drug is now being tested in the PROGNOSTICS project, a research … Read the full press release →

(IN BRIEF) The European Space Agency’s JUICE mission to explore Jupiter and its three largest moons is set to launch, carrying the high-tech detector RADEM developed by the Paul Scherrer Institute. The detector will provide information about the complex radiation … Read the full press release →